MetaADEDB 2.0 @ LMMD
gadoteridol
(DPNNNPAKRZOSMO-UHFFFAOYSA-K)
Structure
SMILES
CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
Type(s)
Approved; Investigational
ATC code(s)
V08CA04
Molecular Formula:
C17H29GdN4O7
Molecular Weight:
558.685
Log P:
-6.4099
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
1
TPSA:
153.58
CAS Number(s):
120066-54-8
Synonym(s)
1.
gadoteridol
2.
Gd(DO3A)
3.
Gd-HP-D03A
4.
Gd-HP-DO3A
5.
Gd-HPDO3A
6.
Gd-hydroxypropyl-D03A
7.
GdHPDO3A
8.
Prohance
9.
SQ 32,692
10.
SQ 32692
11.
SQ-32692
12.
gadolinium 1,4,7-tris(carboxymethyl)-10-(2'-hydroxypropyl)-1,4,7,10-tetraazacyclododecane
13.
gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
14.
gadolinium HP-DO3A
External Link(s)
MeSHC062402
PubChem Compound24838311
44144429
60714
ChEBI31643
CHEMBLCHEMBL1200593
DrugBankDB00597
KEGGdr:D01137
Therapeutic Target DatabaseD0M1PL
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 59SIDER
US FAERS
2HypersensitivityFAERS: 55SIDER
US FAERS
3VomitingFAERS: 36SIDER
US FAERS
4ShockFAERS: 34SIDER
US FAERS
5UrticariaFAERS: 34SIDER
US FAERS
6Anaphylactic shockFAERS: 26SIDER
US FAERS
7DizzinessFAERS: 22SIDER
US FAERS
8SneezingFAERS: 20US FAERS
9Contrast media reactionFAERS: 18US FAERS
10HypotensionFAERS: 18SIDER
US FAERS
11PruritusFAERS: 17SIDER
US FAERS
12Anaphylactoid ReactionFAERS: 15SIDER
US FAERS
13ErythemaFAERS: 12OFFSIDES
SIDER
US FAERS
14PallorFAERS: 12US FAERS
15Burning sensationFAERS: 11OFFSIDES
US FAERS
16TremorFAERS: 11SIDER
US FAERS
17Cold sweatFAERS: 10US FAERS
18MalaiseFAERS: 10SIDER
US FAERS
19AstheniaFAERS: 9OFFSIDES
US FAERS
20Throat irritationFAERS: 9US FAERS
21Respiratory arrestFAERS: 8US FAERS
22Urinary IncontinenceFAERS: 8SIDER
US FAERS
23Cardiac ArrestFAERS: 7SIDER
US FAERS
24Chest discomfortFAERS: 7US FAERS
25Feeling abnormalFAERS: 7SIDER
US FAERS
26PainFAERS: 7OFFSIDES
SIDER
US FAERS
27SyncopeFAERS: 7SIDER
US FAERS
28ArthralgiaFAERS: 6US FAERS
29Back PainFAERS: 6US FAERS
30Chest PainFAERS: 6SIDER
US FAERS
31ChillsFAERS: 6US FAERS
32Contrast media allergyFAERS: 6US FAERS
33Depressed Level of ConsciousnessFAERS: 6SIDER
US FAERS
34Drug ineffectiveFAERS: 6US FAERS
35FatigueFAERS: 6OFFSIDES
US FAERS
36FlushingFAERS: 6SIDER
US FAERS
37LethargyFAERS: 6US FAERS
38No adverse eventFAERS: 6US FAERS
39WheezingFAERS: 6SIDER
US FAERS
40Abdominal PainFAERS: 5SIDER
US FAERS
41Biopsy bone abnormalFAERS: 5US FAERS
42Biopsy brain abnormalFAERS: 5US FAERS
43CyanosisFAERS: 5SIDER
US FAERS
44DisorientationFAERS: 5US FAERS
45HeadacheFAERS: 5SIDER
US FAERS
46RetchingFAERS: 5US FAERS
47TachycardiaFAERS: 5US FAERS
48Unresponsive to stimuliFAERS: 5US FAERS
49AphoniaFAERS: 4US FAERS
50BronchospasmFAERS: 4US FAERS
51DysphoniaFAERS: 4US FAERS
52Feeling ColdFAERS: 4US FAERS
53Foaming at mouthFAERS: 4US FAERS
54Musculoskeletal stiffnessFAERS: 4OFFSIDES
SIDER
US FAERS
55AmnesiaFAERS: 3US FAERS
56AngioedemaFAERS: 3US FAERS
57AnxietyFAERS: 3OFFSIDES
SIDER
US FAERS
58Bone painFAERS: 3OFFSIDES
US FAERS
59BradycardiaFAERS: 3SIDER
US FAERS
60Cerebrovascular accidentFAERS: 3US FAERS
61DysgeusiaFAERS: 3SIDER
US FAERS
62Eye irritationFAERS: 3US FAERS
63Lip swellingFAERS: 3US FAERS
64MyalgiaFAERS: 3US FAERS
65Myocardial InfarctionFAERS: 3US FAERS
66PalpitationsFAERS: 3US FAERS
67Retrograde amnesiaFAERS: 3OFFSIDES
US FAERS
68Upper respiratory tract congestionFAERS: 3US FAERS
69Abdominal discomfortFAERS: 2OFFSIDES
US FAERS
70Acute kidney injuryFAERS: 2US FAERS
71Acute respiratory failureFAERS: 2US FAERS
72AmaurosisFAERS: 2US FAERS
73AsphyxiaFAERS: 2US FAERS
74Biopsy skin abnormalFAERS: 2US FAERS
75BlindnessFAERS: 2US FAERS
76Blood glucose decreasedFAERS: 2US FAERS
77ChokingFAERS: 2US FAERS
78ConstipationFAERS: 2US FAERS
79DermatitisFAERS: 2SIDER
US FAERS
80Electromechanical dissociationFAERS: 2OFFSIDES
US FAERS
81EpilepsyFAERS: 2US FAERS
82Head discomfortFAERS: 2US FAERS
83Infusion site phlebitisFAERS: 2US FAERS
84Limb discomfortFAERS: 2US FAERS
85Memory impairmentFAERS: 2US FAERS
86Muscle RigidityFAERS: 2US FAERS
87Musculoskeletal chest painFAERS: 2US FAERS
88PneumothoraxFAERS: 2US FAERS
89PresyncopeFAERS: 2US FAERS
90Product impurityFAERS: 2US FAERS
91Product quality issueFAERS: 2US FAERS
92RalesFAERS: 2US FAERS
93Respiratory distressFAERS: 2US FAERS
94RhonchiFAERS: 2US FAERS
95SomnolenceFAERS: 2US FAERS
96StridorFAERS: 2US FAERS
97Toxicity to various agentsFAERS: 2US FAERS
98Urticarial vasculitisFAERS: 2US FAERS
99Ventricular FibrillationFAERS: 2US FAERS
100Visual ImpairmentFAERS: 2US FAERS
101Visual acuity reduced transientlyFAERS: 2OFFSIDES
US FAERS
102Wrong drug administeredFAERS: 2US FAERS
103AbscessFAERS: 1US FAERS
104Accidental exposure to productFAERS: 1US FAERS
105Altered state of consciousnessFAERS: 1US FAERS
106Angina PectorisFAERS: 1US FAERS
107AnuriaFAERS: 1US FAERS
108AsthmaFAERS: 1US FAERS
109Blood potassium decreasedFAERS: 1US FAERS
110Blood pressure immeasurableFAERS: 1US FAERS
111Cerebral InfarctionFAERS: 1US FAERS
112Contraindicated product administeredFAERS: 1US FAERS
113Contrast media depositionFAERS: 1US FAERS
114Croup infectiousFAERS: 1US FAERS
115DroolingFAERS: 1US FAERS
116Electrocardiogram abnormalFAERS: 1US FAERS
117Electromagnetic interferenceFAERS: 1US FAERS
118EmbolismFAERS: 1US FAERS
119Erythema MultiformeFAERS: 1US FAERS
120Exposure during breast feedingFAERS: 1US FAERS
121Eye inflammationFAERS: 1US FAERS
122Eye painFAERS: 1US FAERS
123Feeling jitteryFAERS: 1US FAERS
124Flank PainFAERS: 1US FAERS
125HoarsenessFAERS: 1US FAERS
126HyperventilationFAERS: 1US FAERS
127HypoxiaFAERS: 1US FAERS
128Inappropriate affectFAERS: 1US FAERS
129IncoherentFAERS: 1US FAERS
130IncontinenceFAERS: 1US FAERS
131Incorrect route of drug administrationFAERS: 1US FAERS
132Incorrect route of product administrationFAERS: 1US FAERS
133Increased upper airway secretionFAERS: 1US FAERS
134InflammationFAERS: 1US FAERS
135Injection site inflammationFAERS: 1US FAERS
136Joint destructionFAERS: 1US FAERS
137Lip pruritusFAERS: 1US FAERS
138Mental status changesFAERS: 1US FAERS
139MetastasisFAERS: 1US FAERS
140Mouth swellingFAERS: 1US FAERS
141Musculoskeletal PainFAERS: 1US FAERS
142Nasal discomfortFAERS: 1US FAERS
143Nasal pruritusFAERS: 1US FAERS
144Nephrogenic Fibrosing DermopathyFAERS: 1OFFSIDES
US FAERS
145NervousnessFAERS: 1US FAERS
146Oculogyric crisisFAERS: 1US FAERS
147OnychalgiaFAERS: 1US FAERS
148Orthostatic tremorFAERS: 1US FAERS
149PetechiaeFAERS: 1US FAERS
150Procedural complicationFAERS: 1US FAERS
151Productive CoughFAERS: 1US FAERS
152Quality of life decreasedFAERS: 1OFFSIDES
US FAERS
153Reflux laryngitisFAERS: 1US FAERS
154Respiratory DepressionFAERS: 1US FAERS
155RestlessnessFAERS: 1US FAERS
156Seizure like phenomenaFAERS: 1US FAERS
157Septic ShockFAERS: 1US FAERS
158Shock symptomFAERS: 1US FAERS
159Sinoatrial BlockFAERS: 1US FAERS
160Skin discomfortFAERS: 1US FAERS
161Skin tightnessFAERS: 1OFFSIDES
US FAERS
162StomatitisFAERS: 1US FAERS
163TetanyFAERS: 1US FAERS
164Thrombosis in deviceFAERS: 1US FAERS
165ToothacheFAERS: 1US FAERS
166Tracheal StenosisFAERS: 1US FAERS
167Urinary RetentionFAERS: 1US FAERS
168Urinary tract infectionFAERS: 1US FAERS
169Vascular painFAERS: 1US FAERS
170Wrong technique in product usage processFAERS: 1US FAERS
171YawningFAERS: 1OFFSIDES
US FAERS
172AbasiaOFFSIDES
173Abdominal CrampsSIDER
174Activities of daily living impairedOFFSIDES
175Adverse eventOFFSIDES
176AmputationOFFSIDES
177AnhedoniaOFFSIDES
178ArthritisOFFSIDES
179ArthropathyOFFSIDES
180BereavementOFFSIDES
181Bone density decreasedOFFSIDES
182BronchopneumoniaOFFSIDES
183CalcinosisOFFSIDES
184Catheter site erythemaOFFSIDES
185ContractureOFFSIDES
186DemyelinationOFFSIDES
187DiscomfortSIDER
188Dry skinOFFSIDES
189Emotional distressOFFSIDES
190EscharOFFSIDES
191ExcoriationOFFSIDES
192Exfoliative rashOFFSIDES
193Extremity contractureOFFSIDES
194Eye InfectionOFFSIDES
195Eye RednessOFFSIDES
196FormicationOFFSIDES
197General physical health deteriorationOFFSIDES
198GingivitisSIDER
199GranulomaOFFSIDES
200HyperkeratosisOFFSIDES
201HyperpigmentationOFFSIDES
202Hypertensive emergencyOFFSIDES
203Impaired self-careOFFSIDES
204Impaired work abilityOFFSIDES
205IndurationOFFSIDES
206Infusion site mobility decreasedOFFSIDES
207Injection Site ReactionSIDER
208Injection site painSIDER
209Joint Range of Motion DecreasedOFFSIDES
210Joint stiffnessOFFSIDES
211LaryngospasmSIDER
212LichenificationOFFSIDES
213Life expectancy shortenedOFFSIDES
214Livedo ReticularisOFFSIDES
215LymphedemaOFFSIDES
216MetaplasiaOFFSIDES
217Muscle FatigueOFFSIDES
218Muscle WeaknessOFFSIDES
219Muscle fibrosisOFFSIDES
220Muscle tightnessOFFSIDES
221Musculoskeletal discomfortOFFSIDES
222Myocardial fibrosisOFFSIDES
223MyosclerosisOFFSIDES
224Neck stiffnessSIDER
225Nephrogenic Systemic FibrosisSIDER
226NeuralgiaOFFSIDES
227Nodule on extremityOFFSIDES
228Nuchal RigiditySIDER
229Ocular icterusOFFSIDES
230Open woundOFFSIDES
231Pain of skinOFFSIDES
232Physical disabilityOFFSIDES
233PingueculaOFFSIDES
234Postoperative renal failureOFFSIDES
235Pulmonary function test decreasedOFFSIDES
236QRS axis abnormalOFFSIDES
237QuadriparesisOFFSIDES
238RhinitisSIDER
239SclerodactyliaOFFSIDES
240SclerodermaOFFSIDES
241Skin ErosionOFFSIDES
242Skin IndurationOFFSIDES
243Skin WrinklingOFFSIDES
244Skin hypertrophyOFFSIDES
245Skin lesionOFFSIDES
246Skin necrosisOFFSIDES
247Spinal column stenosisOFFSIDES
248SpondylitisOFFSIDES
249StaringSIDER
250Stasis dermatitisOFFSIDES
251StressOFFSIDES
252StuporSIDER
253Subcutaneous noduleOFFSIDES
254SweatingSIDER
255TinnitusSIDER
256Unevaluable eventOFFSIDES
257XerosisOFFSIDES
258effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.